Author

Anoushka Kathiravan

University of California, Los Angeles

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Angeliki Diotima IoannidisiD· 2 shared Frank PajonkiD· 2 shared Ling HeiD· 2 shared Purva JoshiiD· 2 shared Carter J. HoffmaniD· 1 shared Evelyn ArambulaiD· 1 shared Harley I. KornblumiD· 1 shared Julian P. WhiteleggeiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 40 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Angeliki Diotima IoannidisORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyRadiation ResearchPeer-reviewedApr 23, 2026

Repurposing Quetiapine as an Adjuvant Therapeutic Agent for Triple-Negative Breast Cancer

Ling He, Purva Joshi, Angeliki Diotima Ioannidis…·Frank Pajonk

This study evaluates quetiapine as an adjuvant therapy for triple-negative breast cancer, showing it reduces clonogenicity, promotes apoptosis, and impairs DNA repair and migration.

2 citations

humanbulk RNA-seq

𝕏 PostBluesky

NeuroscienceCancer Research CommunicationsPeer-reviewedJun 5, 2024

Activation of the mevalonate pathway in response to anti-cancer treatments drives glioblastoma recurrences through activation of Rac-1

Ling He, Angeliki Diotima Ioannidis, Evelyn Arambula…·Frank Pajonk

This study shows that activation of the mevalonate pathway and Rac-1 in glioblastoma cells after anti-cancer treatments promotes recurrence, and statins combined with radiation improve survival in mouse models.

5 citations

mousebulk RNA-seq

𝕏 PostBluesky